Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 28, 2024 09:00 ET | Source: BioCardia, Inc.

BioCardia Completes Phase III Randomized Double-Blind Controlled Trial of Autologous Cell Therapy for Ischemic Heart Failure

BioCardia announced today the completion of its last protocol specified follow-up visit in CardiAMP HF multi-center trial.